Kirsten M. Kliphouse - 06 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kirsten M. Kliphouse
Issuer symbol
LH
Transactions as of
06 Feb 2024
Net transactions value
$0
Form type
4
Filing time
08 Feb 2024, 12:46:59 UTC
Previous filing
30 Oct 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +947 +255% 1,319 07 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Award $0 +944 +100% $0.000000 1,891 06 Feb 2024 Common Stock 944 Direct F1, F2, F3
transaction LH Restricted Stock Unit Options Exercise $0 -947 -50% $0.000000 944 07 Feb 2024 Common Stock 947 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vest fully on February 6, 2025.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4 The Restricted Stock Units vested fully on February 7, 2024.